1. Meta-analysis of Genetic polymorphism of Enhancer of Zeste Homolog2 gene in cancer susceptibility
    Nisha Gautam et al, 2023, Journal of Cancer Research and Therapeutics CrossRef
  2. EZH2 Single Nucleotide Variants (SNVs): Diagnostic and Prognostic Role in 10 Solid Tumor Types
    Elisa Paolicchi et al, 2017, Epigenomes CrossRef
  3. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2
    Anthos Christofides et al, 2016, Oncotarget CrossRef
  4. Biomolecular prognostic factors in Klatskin tumor
    Yu. O. Zharikov et al, 2016, Khirurgiya. Zhurnal im. N.I. Pirogova CrossRef
  5. Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis
    Shao-Jun Ma et al, 2018, Bioscience Reports CrossRef
  6. Portal cholangiocarcinoma: epidemiology, staging principles and aspects of tumor biology
    Yu. A. Kovalenko et al, 2017, Khirurgiya. Zhurnal im. N.I. Pirogova CrossRef
  7. EZH2 as a potential therapeutic target for gastrointestinal cancers
    Mehrdad Hashemi et al, 2024, Pathology - Research and Practice CrossRef
  8. Elevated expression of a pharmacologic Polycomb signature predicts poor prognosis in gastric and breast cancer
    Pier-Luc Clermont et al, 2017, Epigenomics CrossRef
  9. Genome–epigenome interactions: the Polycomb paradox
    Francesco Crea et al, 2014, Epigenomics CrossRef
  10. Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?
    Chiara Braconi et al, 2019, Liver International CrossRef
  11. A novel insight of Asp193His mutation on epigenetic methyltransferase activity of human EZH2 protein: An in-silico approach
    Nisha Gautam et al, 2019, Meta Gene CrossRef
  12. Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
    Sandra Pavicevic et al, 2022, Cancers CrossRef
  13. Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report
    Joseph Hatem et al, 2016, Diagnostic Pathology CrossRef
  14. WITHDRAWN: A novel insight of Asp193His mutation on epigenetic methyltransferase activity of human EZH2 protein: An in-silico approach
    Nisha Gautam et al, 2019, Informatics in Medicine Unlocked CrossRef
  15. The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic Review
    Guanwu Wang et al, 2022, Cancers CrossRef
  16. Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine
    Ines Malenica et al, 2020, Cancers CrossRef
  17. EZH2 Expression and Survival for ER+/tamoxifen Treated Breast Cancer Patients with rs2302427 C>G: A Novel Prognostic and Risk Predictive Biomarker
    Nisha Gautam et al, 2023, Archives of Medical Research CrossRef